genomiQa offers hospitals, clinicians, researchers, and biopharma companies high-quality analysis of data from whole genome sequencing. We bring precision analytics to routine clinical practice. In practice this offers:
- More accurate diagnostics
- Better decision support for clinicians
- Precision drug development
genomiQa is a start-up company that has grown out of the QIMR Berghofer Medical Research Institute—now a major shareholder and where genomiQa is based. Founders, Dr Nic Waddell and John Pearson, have more than 35 years’ combined experience in genomics and bioinformatics. These areas of expertise blend powerfully within genomiQa’s products and services, which are designed to support personalised treatment and better outcomes for patients.